Dahring Cusmano’s Johnson & Johnson JNJ Stock Holding History

Dahring Cusmano’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,311	Closed	-$243K	–	51
2025 Q3	$243K	Sell	1,311 -3,208	-71%	-$550K	0.18%	49
2025 Q2	$690K	Buy	4,519 +4	+0.1%	+$615	0.54%	23
2025 Q1	$749K	Sell	4,515 -8	-0.2%	-$1.25K	0.64%	21
2024 Q4	$654K	Buy	+4,523	New	+$701K	0.59%	23

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dahring Cusmano's JNJ Position: Q4 2025 in Review

Dahring Cusmano sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 1,311 shares — an estimated $243K sold.

Dahring Cusmano first reported a position in JNJ in Q4 2024 and held it in 4 quarters. The position peaked at $749K in Q1 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Dahring Cusmano reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
Dahring Cusmano sold 1,311 Johnson & Johnson shares in Q4 2025, an estimated $243K.
Dahring Cusmano first reported a position in Johnson & Johnson in Q4 2024 and held it in 4 quarters.
Dahring Cusmano's Johnson & Johnson position peaked at $749K in Q1 2025.
4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Dahring Cusmano's 13F filing for Q4 2025, filed 5 Feb 2026.